NCT06203834Completed
Evaluating the Efficacy of I-fiber Pearl on Reducing Body Fat Accumulation in Obese Subjects
Evaluating the Efficacy of I-fiber Pearl on Reducing Body Fat Accumulation in Obese Subjects: a Randomized, Double-blind, and Placebo-controlled Trial
Source: ClinicalTrials.gov · Last updated 27 Dec 2024
Brief summary (registry, in English)
The aim of this study is to investigate the effects of I-Fiber Pearl on Body Weight and Body Fat in Obese Adults.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 3 Jan 2024
- Start date
- 1 Nov 2023
- Primary completion date
- 18 Sept 2024
- Lead sponsor
- Chung Shan Medical University
- Diseases
- Obesity
- NCT number
- NCT06203834
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 1 Nov 2023 to the primary completion date, 18 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who use other drugs whose pharmacological effects may affect the experiment or may aggravate the effects of the drug.
Other illness
- Subjects diagnosed with cancer and on curative care.
- Subjects diagnosed with heart disease and on curative care.
- Subjects with systemic infection requiring antibiotics.
Who the study is looking for
- female
- aged 20-50 years old
- body mass index is greater than or equal to 27 kg/m2
- waist greater than or equal to 80 cm
Age in the registry: 20 years to 50 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chung Shan Medical University Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.